2021
DOI: 10.1101/2021.09.06.459071
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

eIF6 rebinding dynamically couples ribosome maturation and translation

Abstract: Protein synthesis is a cyclical process consisting of translation initiation, elongation, termination and ribosome recycling. The release factors SBDS and EFL1 (both mutated in the leukaemia predisposition disorder Shwachman-Diamond syndrome) license entry of nascent 60S ribosomal subunits into active translation by evicting the anti-association factor eIF6 from the 60S intersubunit face. Here, we show that in mammalian cells, eIF6 holds all free cytoplasmic 60S subunits in a translationally inactive state and… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 55 publications
(73 reference statements)
0
1
0
Order By: Relevance
“…[21] This probably brings about a reduced dose of EIF6 in SBDS-de cient HSPCs, which may help bypass the restraint on growth by ameliorating the defect in ribosomal subunit joining, in turn favouring the formation of actively translating 80S ribosomes and provide a clonal tness advantage. [21][22][23][24] This mechanism probably underlie the stable clinical course of case 2. The exploration of this mechanism provides insight for the treatment of other SDS patients without del20q.…”
Section: Discussionmentioning
confidence: 84%
“…[21] This probably brings about a reduced dose of EIF6 in SBDS-de cient HSPCs, which may help bypass the restraint on growth by ameliorating the defect in ribosomal subunit joining, in turn favouring the formation of actively translating 80S ribosomes and provide a clonal tness advantage. [21][22][23][24] This mechanism probably underlie the stable clinical course of case 2. The exploration of this mechanism provides insight for the treatment of other SDS patients without del20q.…”
Section: Discussionmentioning
confidence: 84%